Comparative Safety and Effectiveness of Ustekinumab and Anti-TNF in Elderly Crohn's Disease Patients.

Gerum Gashaw GebeyehuGiacomo BroglioEleanor LiuJimmy K LimdiChristian SelingerJoseph FiskeVioleta RazanskaitePhilip J SmithPaul K FlanaganSreedhar Subramanian

Published in: Inflammatory bowel diseases (2024)

We observed comparable safety and effectiveness for ustekinumab and anti-TNF agents in treating elderly CD patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
rheumatoid arthritis
prognostic factors
middle aged
patient reported outcomes